AnalystsDaina GrayboschDaina Graybosch's Stock Forecasts
AnalystsDaina Graybosch
Sectors:
Industries:
Analyst Ranking
Bottom 1%
#5301 out of 5340 analysts
Average Return
-20.44%
Win Rate
33%30 out of 90
Risk vs Reward
Poor
Good
Daina Graybosch's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arcellx IncACLX | +366.89% | $8.91 | $41.60 | 2022-05-13 - 2023-05-12 | Buy |
F Star Therapeutics IncFSTX | +162.96% | $2.43 | $6.39 | 2022-05-11 - 2022-06-24 | Buy |
Arcellx IncACLX | +127.81% | $30.53 | $69.55 | 2023-03-30 - 2024-03-28 | Buy |
Arcellx IncACLX | +115.76% | $14.02 | $30.25 | 2022-03-29 - 2023-03-28 | Buy |
Affimed NvAFMDQ | +103.18% | $40.90 | $83.10 | 2020-06-24 - 2021-06-24 | Buy |
Daina Graybosch Analyst Color
Get additional color on Daina Graybosch's coverage of popular stocks
Daina Graybosch's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Gilead Sciences IncGILD | 1 | Hold | $127.00 | -3.26% | Downgrades | 11 days ago |
Arcellx IncACLX | 6 | Hold | $115.00 | -0.06% | Downgrades | 5 months ago |
Century Therapeutics IncIPSC | 5 | Hold | $2.00 | -8.68% | Downgrades | 8 months ago |
Novabridge BiosciencesNBP | 1 | Buy | $9.00 | +448.78% | Initiates Coverage On | 10 months ago |
Innate Pharma SaIPHA | 10 | Hold | $2.00 | +14.61% | Downgrades | 10 months ago |
Xilio Therapeutics IncXLO | 1 | Buy | $28.00 | +208.37% | Initiates Coverage On | a year ago |
Adagene IncADAG | 1 | Buy | $7.00 | +87.67% | Initiates Coverage On | a year ago |
Summit Therapeutics IncSMMT | 1 | Sell | $12.00 | N/A | Initiates Coverage On | a year ago |
Iteos Therapeutics IncITOS | 5 | Hold | $9.00 | N/A | Downgrades | a year ago |
Affimed NvAFMDQ | 8 | Hold | $0.39 | N/A | Downgrades | a year ago |
2seventy Bio IncTSVT | 5 | Hold | $5.00 | N/A | Downgrades | a year ago |
Merck & Co IncMRK | 16 | Buy | $119.00 | N/A | Maintains | 2 years ago |
Lava Therapeutics NvLVTX | 6 | Hold | $2.00 | N/A | Downgrades | 2 years ago |
Bolt Biotherapeutics IncBOLT | 8 | Hold | $20.00 | N/A | Downgrades | 2 years ago |
Nektar TherapeuticsNKTR | 10 | Hold | $45.00 | N/A | Maintains | 3 years ago |
Fate Therapeutics IncFATE | 6 | Buy | $10.00 | N/A | Maintains | 4 years ago |
Arcus Biosciences IncRCUS | 2 | Buy | $38.00 | N/A | Maintains | 4 years ago |
Molecular Partners AgMOLN | 4 | Hold | $8.00 | N/A | Downgrades | 4 years ago |
Biontech SeBNTX | 13 | Buy | $224.00 | N/A | Maintains | 4 years ago |
Nkarta IncNKTX | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 4 years ago |
F Star Therapeutics IncFSTX | 4 | Hold | $7.00 | N/A | Downgrades | 4 years ago |
Werewolf Therapeutics IncHOWL | 3 | Buy | $17.00 | N/A | Maintains | 4 years ago |
Ars Pharmaceuticals IncSPRY | 6 | Hold | $1.80 | N/A | Downgrades | 4 years ago |
Compugen LtdCGEN | 2 | Buy | $9.00 | N/A | Maintains | 4 years ago |
Genocea Biosciences IncGNCAQ | 1 | Buy | $6.00 | N/A | Maintains | 5 years ago |
Synthorx IncTHOR2 | 1 | Hold | $68.00 | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.